Royal Bank of Canada’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-99,000
Closed -$4.95M 7755
2021
Q3
$4.95M Buy
+99,000
New +$5.4M ﹤0.01% 2297

Other funds holding HCAT

Royal Bank of Canada's HCAT Position: Q1 2026 in Review

Royal Bank of Canada sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 1,305 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in HCAT in Q3 2019 and held it in 26 quarters. The position peaked at $16.5M in Q4 2021. 131 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Royal Bank of Canada reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 1,305 Health Catalyst shares in Q1 2026, an estimated $3K.
  • Royal Bank of Canada first reported a position in Health Catalyst in Q3 2019 and held it in 26 quarters.
  • Royal Bank of Canada's Health Catalyst position peaked at $16.5M in Q4 2021.
  • 131 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.